Get the Stockscreener App
606.46
6.73%
38.23
After Hours:
606.74
0.28
+0.05%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $606.46, with a volume of 3.02M.
It is up +6.73% in the last 24 hours and up +16.89% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
See More
Previous Close:
$568.23
Open:
$590.6
24h Volume:
3.02M
Relative Volume:
1.65
Market Cap:
$231.78B
Revenue:
$42.37B
Net Income/Loss:
$6.14B
P/E Ratio:
38.02
EPS:
15.95
Net Cash Flow:
$7.78B
1W Performance:
+5.50%
1M Performance:
+16.89%
6M Performance:
-1.40%
1Y Performance:
+6.94%
1-Day Range:
$590.00
$610.97
1-Week Range:
$566.70
$610.97
52-Week Range:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
606.46 | 231.78B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
223.07 | 159.92B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
151.36 | 43.41B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.74 | 36.50B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
423.99 | 34.79B | 3.84B | 866.24M | 792.60M | 10.37 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcript - AOL
New products drive Thermo Fisher earnings - 69News WFMZ-TV
Thermo Fisher Stock Surges 6.6% as Q4 Earnings Smash Estimates--Can It Keep the Momentum in 2025? - Yahoo Finance
Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates - Investopedia
Thermo Fisher CEO: 'We'll manage through' Trump policy changes - The Business Journals
Thermo Fisher Scientific Gaps Up And Nears A Buy Point On Strong Earnings Beat - Inkl
Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up - Yahoo Finance
Thermo Fisher sees robust 2025 profit on improved demand for its tools and services - Reuters
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by Manning & Napier Advisors LLC - MarketBeat
Thermo Fisher stock higher after Q4 beat (TMO:NYSE) - Seeking Alpha
Earnings call transcript: Thermo Fisher Scientific beats Q4 2024 forecasts - Investing.com
Thermo Fisher (TMO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands - Benzinga
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by New England Research & Management Inc. - MarketBeat
Raymond James maintains Thermo Fisher Outperform, $650 target - Investing.com India
Why Thermo Fisher Scientific (TMO) Is the Best Stock to Buy in 2025 for Beginners - Yahoo Finance
Thermo Fisher Exceeds Q4 Earnings Expectations and Revenue TargetsNews and Statistics - IndexBox, Inc.
Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance Australia
Thermo Fisher Tops Estimates With Strong Demand In Therapy Development - Finimize
Thermo Fisher Scientific Exceeds Q4 2024 Expectations with $4.78 EPS and $11.40 Billion Revenue - GuruFocus.com
Thermo Fisher Scientific beats Q4 estimates, shares rise - Investing.com
Thermo Fisher beats quarterly estimates on strong demand for its tools and services -January 30, 2025 at 06:52 am EST - Marketscreener.com
Thermo Fisher Sees Robust 2025 Profit on Improved Demand for Its Tools and Services - U.S News & World Report Money
Thermo Fisher Scientific Profit, Revenue Rose in 4Q - MarketWatch
Thermo Fisher Scientific earnings beat by $0.15, revenue topped estimates - Investing.com Canada
Thermo Fisher: Q4 Earnings Snapshot -January 30, 2025 at 06:19 am EST - Marketscreener.com
Thermo Fisher: Q4 Earnings Snapshot - Milton Daily Standard
Thermo Fisher Scientific's Q4 Adjusted Earnings, Revenue Rise -January 30, 2025 at 06:10 am EST - Marketscreener.com
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results - The Bakersfield Californian
Oligonucleotide CDMO Global Market Report 2025, with - GlobeNewswire
Is Thermo Fisher Scientific Inc. (TMO) the Safe Stock to Buy for the Long Term in 2025? - Insider Monkey
Thermo Fisher considering moving operations; negotiations underway with Middleton, state - WKOW
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Robeco Institutional Asset Management B.V. Acquires 30,758 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Q4 2024 Earnings Preview - MSN
Smart Money Is Betting Big In TMO Options - Benzinga
Single Use Assemblies Market Global Forecasts to 2029: Rapid Growth in Single-Use Assemblies Market Driven by Biologics and Biosimilars Demand - GlobeNewswire Inc.
Earnings Preview: Thermo Fisher Is Facing Way Too Many Headwinds (NYSE:TMO) - Seeking Alpha
Orrstown Financial Services Inc. Has $659,000 Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Swedbank AB Acquires 228,475 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Forsta AP Fonden Cuts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Hantz Financial Services Inc. Reduces Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
McKinley Carter Wealth Services Inc. Sells 562 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Emission Monitoring System Market 2025 Industry Analysis, Top - openPR
Celiac Disease Testing Market Statistical Forecast, Trade - openPR
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Pacer Advisors Inc. - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Blue Trust Inc. - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Kingswood Wealth Advisors LLC - MarketBeat
12 Best Stocks to Buy in 2025 for Beginners - Insider Monkey
Thermo Fisher Scientific Inc. (TMO): Is This Healthcare Stock A Good Buy? - Yahoo Finance
Curbstone Financial Management Corp Buys Shares of 1,316 Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
2.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):